Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 4
1967 2
1968 5
1969 5
1970 8
1971 14
1972 10
1973 5
1974 10
1975 5
1976 7
1977 6
1978 11
1979 8
1980 18
1981 8
1982 9
1983 18
1984 13
1985 19
1986 27
1987 24
1988 32
1989 28
1990 33
1991 42
1992 28
1993 40
1994 56
1995 63
1996 65
1997 48
1998 59
1999 57
2000 79
2001 89
2002 78
2003 76
2004 93
2005 82
2006 72
2007 60
2008 58
2009 43
2010 41
2011 33
2012 38
2013 31
2014 36
2015 22
2016 38
2017 34
2018 30
2019 20
2020 19
2021 24
2022 28
2023 5
Text availability
Article attribute
Article type
Publication date

Search Results

1,802 results
Results by year
Filters applied: . Clear all
Page 1
Crinecerfont Lowers Elevated Hormone Markers in Adults With 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia.
Auchus RJ, Sarafoglou K, Fechner PY, Vogiatzi MG, Imel EA, Davis SM, Giri N, Sturgeon J, Roberts E, Chan JL, Farber RH. Auchus RJ, et al. J Clin Endocrinol Metab. 2022 Feb 17;107(3):801-812. doi: 10.1210/clinem/dgab749. J Clin Endocrinol Metab. 2022. PMID: 34653252 Free PMC article. Clinical Trial.
Main outcomes included changes from baseline to day 14 in adrenocorticotropin (ACTH), 17-hydroxyprogesterone (17OHP), androstenedione, and testosterone. ...
Main outcomes included changes from baseline to day 14 in adrenocorticotropin (ACTH), 17-hydroxyprogesterone (17OHP), androste …
17-OHPC to Prevent Recurrent Preterm Birth in Singleton Gestations (PROLONG Study): A Multicenter, International, Randomized Double-Blind Trial.
Blackwell SC, Gyamfi-Bannerman C, Biggio JR Jr, Chauhan SP, Hughes BL, Louis JM, Manuck TA, Miller HS, Das AF, Saade GR, Nielsen P, Baker J, Yuzko OM, Reznichenko GI, Reznichenko NY, Pekarev O, Tatarova N, Gudeman J, Birch R, Jozwiakowski MJ, Duncan M, Williams L, Krop J. Blackwell SC, et al. Am J Perinatol. 2020 Jan;37(2):127-136. doi: 10.1055/s-0039-3400227. Epub 2019 Oct 25. Am J Perinatol. 2020. PMID: 31652479 Free article. Clinical Trial.
BACKGROUND: Women with a history of spontaneous preterm birth (SPTB) are at a significantly increased risk for recurrent preterm birth (PTB). To date, only one large U.S. clinical trial comparing 17-OHPC (17-alpha-hydroxyprogesterone caproate or "17P") …
BACKGROUND: Women with a history of spontaneous preterm birth (SPTB) are at a significantly increased risk for recurrent preterm birth (PTB) …
Vaginal progesterone vs intramuscular 17-hydroxyprogesterone caproate for prevention of recurrent preterm birth: a randomized controlled trial.
Boelig RC, Schoen CN, Frey H, Gimovsky AC, Springel E, Backley S, Berghella V. Boelig RC, et al. Am J Obstet Gynecol. 2022 May;226(5):722.e1-722.e12. doi: 10.1016/j.ajog.2022.02.012. Epub 2022 Feb 19. Am J Obstet Gynecol. 2022. PMID: 35189093 Clinical Trial.
Based on the estimated recurrent preterm birth rate of 36% with 17-hydroxyprogesterone caproate, 95 participants were needed in each arm to detect a 50% reduction in preterm birth rate with vaginal progesterone, with 80% power and 2-sided alpha of 0.05. ...RE …
Based on the estimated recurrent preterm birth rate of 36% with 17-hydroxyprogesterone caproate, 95 participants were needed i …
Effect of Lepidium meyenii (Maca), a root with aphrodisiac and fertility-enhancing properties, on serum reproductive hormone levels in adult healthy men.
Gonzales GF, Córdova A, Vega K, Chung A, Villena A, Góñez C. Gonzales GF, et al. J Endocrinol. 2003 Jan;176(1):163-8. doi: 10.1677/joe.0.1760163. J Endocrinol. 2003. PMID: 12525260 Clinical Trial.
Serum levels of luteinizing hormone, follicle-stimulating hormone, prolactin, 17-alpha hydroxyprogesterone, testosterone and 17-beta estradiol were measured before and at 2, 4, 8 and 12 weeks of treatment with placebo or Maca (1.5 g or 3.0 g per day). …
Serum levels of luteinizing hormone, follicle-stimulating hormone, prolactin, 17-alpha hydroxyprogesterone, testosteron …
Effects of three contraceptive methods on depression and sexual function: An ancillary study of the ECHO randomized trial.
Singata-Madliki M, Carayon-Lefebvre d'Hellencourt F, Lawrie TA, Balakrishna Y, Hofmeyr GJ. Singata-Madliki M, et al. Int J Gynaecol Obstet. 2021 Aug;154(2):256-262. doi: 10.1002/ijgo.13594. Epub 2021 Mar 2. Int J Gynaecol Obstet. 2021. PMID: 33448029 Free PMC article. Clinical Trial.
Contrary to our hypothesis, at 12 months, depression was lowest among DMPA-IM users (16/167, 9.6%) and highest among IUD users (28/158, 17.7%) (p = 0.032). There was little difference in sexual function at any time-point. ...
Contrary to our hypothesis, at 12 months, depression was lowest among DMPA-IM users (16/167, 9.6%) and highest among IUD users (28/158, 1 …
Evaluation of the Safety and Efficacy of Ormeloxifene, a Selective Estrogen Receptor Modulator and Medroxyprogesterone Acetate in Women with Non-Structural Abnormal Uterine Bleeding: A Randomized Clinical Trial.
Mir SA, Ara R, Amin F, Malik A, Hamid L, Ali T, Bader GN, Wani SUD, Almuqbil M, Alshehri S, Alshehri AM, Shakeel F. Mir SA, et al. Medicina (Kaunas). 2022 Oct 22;58(11):1503. doi: 10.3390/medicina58111503. Medicina (Kaunas). 2022. PMID: 36363460 Free PMC article. Clinical Trial.
Comparison of oral Dydrogesterone and 17-α hydroxyprogesterone caprate in the prevention of preterm birth.
Alizadeh F, Mahmoudinia M, Mirteimoori M, Pourali L, Niroumand S. Alizadeh F, et al. BMC Pregnancy Childbirth. 2022 Mar 1;22(1):167. doi: 10.1186/s12884-022-04509-1. BMC Pregnancy Childbirth. 2022. PMID: 35232423 Free PMC article. Clinical Trial.
This study was performed to compare oral Dydrogesterone with intramuscular 17alpha-hydroxyprogesterone caproate (17alpha-OHPC) administration in prevention of PTB. ...Latency period was significantly longer in the progesterone group compared with Dydrogesterone and control …
This study was performed to compare oral Dydrogesterone with intramuscular 17alpha-hydroxyprogesterone caproate (17alpha-OHPC) admini …
Progesterone receptor polymorphisms and clinical response to 17-alpha-hydroxyprogesterone caproate.
Manuck TA, Lai Y, Meis PJ, Dombrowski MP, Sibai B, Spong CY, Rouse DJ, Durnwald CP, Caritis SN, Wapner RJ, Mercer BM, Ramin SM. Manuck TA, et al. Am J Obstet Gynecol. 2011 Aug;205(2):135.e1-9. doi: 10.1016/j.ajog.2011.03.048. Epub 2011 Apr 8. Am J Obstet Gynecol. 2011. PMID: 21600550 Free PMC article. Clinical Trial.
OBJECTIVE: Seventeen-alpha-hydroxyprogesterone caproate (17-OHPC) reduces recurrent preterm birth (PTB). We hypothesized that single nucleotide polymorphisms in the human progesterone receptor (PGR) affect response to 17-OHPC in the prevention of recur …
OBJECTIVE: Seventeen-alpha-hydroxyprogesterone caproate (17-OHPC) reduces recurrent preterm birth (PTB). We hypothesize …
Comparison the efficacy of vaginal progesterone versus 17-alpha-hydroxyprogesterone caproate to prevent preterm birth in high-risk pregnant women undergo cerclage: a randomized clinical trial.
Alavi A, Ranjbar A, Atighpoor F, Zare S. Alavi A, et al. J Matern Fetal Neonatal Med. 2022 Dec;35(25):7438-7444. doi: 10.1080/14767058.2021.1949451. Epub 2021 Sep 1. J Matern Fetal Neonatal Med. 2022. PMID: 34470137 Clinical Trial.
OBJECTIVE: The aim of this study was to compare the effect of vaginal progesterone with 17-alpha-hydroxyprogesterone caproate (17OHP-C) in prevention of preterm birth in high-risk pregnant women undergo cerclage. ...CONCLUSIONS: Vaginal progesterone and 17OHP …
OBJECTIVE: The aim of this study was to compare the effect of vaginal progesterone with 17-alpha-hydroxyprogesterone ca …
Contraceptive method preference and reasons for contraceptive discontinuation among women randomized to intramuscular depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant: Findings from Durban, South Africa.
Beesham I, Bosman S, Beksinska M, Scoville CW, Smit J, Nanda K. Beesham I, et al. Contraception. 2022 Apr;108:37-43. doi: 10.1016/j.contraception.2021.11.002. Epub 2021 Nov 27. Contraception. 2022. PMID: 34848180 Free article. Clinical Trial.
1,802 results